The on/go™ COVID-19 Antigen Self-Test is a rapid, lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens from individuals with or without symptoms or other epidemiological reasons to suspect a COVID-19 infection when tested twice over two or three days with at least 24 hours and not more than 48 hours between tests. This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal swab samples from individuals aged 2 years or older.
FDA-AUTHORIZED, VARIANT-READY SOLUTION
PROVEN CLINICAL EXCELLENCE
Best in class clinical performance, FDA authorized
Comparison of On/Go to the leading FDA authorized competitors:
TAKEN TOGETHER WE PROVIDE...
• Rapid result interpretation • Unique companion app: delightful experience and real-life accuracy boost • Top-quality US production
Developed by Silicon Valley experts, approved by Apple & Google
○ 10-minute test read ○ Artiﬁcial intelligence to support result reading ○ Guided process reduces errors ○ Inbuilt communication platform ○ Fully secure and protective of privacy, built for accessibility